Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Dexmedetomidine for Treatment of Shivering During Cesarean Section Under Neuraxial Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cesarean delivery under neuraxial anesthesia (epidural or spinal) planned or unplanned between 8 am and 8 pm on week days when one of the investigator is present.~* Participants with fever or shivering before the cesarean section are include~Exclusion Criteria:~* No comprehension of french or english language~* Urgent cesarean delivery for non reassuring fetal tracing~* Extremely urgent cesarean delivery (grade 1)~* Weight \< 60 kg ou \> 120 kg~* Hypersensibility to dexmedetomidine~* Heart, renal or hepatic disease requiring follow up, medication or with a possibility of instability during cesarean delivery~* Pre-eclampsia~* Combined spinal-epidural anesthesia~* Conversion into general anesthesia~* Blood products transfusions or major complications during surgery

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dexmedetomidine (Type: ACTIVE_COMPARATOR): Dexmedetomidine 4 mcg/ml, 30 mcg (7,5 ml), single intravenous bolus
- Normal saline (Type: PLACEBO_COMPARATOR): NaCl 0,9% 7,5 ml, single intravenous bolus

Based on this trial design, predict the completion outcome and termination type (if applicable).